Evaluation of bone marrow reticulin in patients with chronic immune thrombocytopenia treated with eltrombopag: Data from the EXTEND study

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|90|7|598-601

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.7, 2015-07, pp. : 598-601

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A 2-Year, Longitudinal, Prospective Study of the Effects of Eltrombopag on Bone Marrow in Patients with Chronic Immune Thrombocytopenia

By  

Acta Haematologica, Vol. 137, Iss. 2, 2016-12 ,pp. : 66-72

Karger

Access to resources Recommend Favorite

Usage of Eltrombopag for Chronic Immune Thrombocytopenia as a Pretreatment for Splenectomy

By  

Acta Haematologica, Vol. 129, Iss. 1, 2012-10 ,pp. : 45-47

Karger

Access to resources Recommend Favorite

United Kingdom immune thrombocytopenia registry: retrospective evaluation of bone marrow fibrosis in adult patients with primary immune thrombocytopenia and correlation with clinical findings

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 4, 2015-05 ,pp. : 590-594

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 3, 2015-03 ,pp. : E40-E43

John Wiley & Sons Inc

Access to resources Recommend Favorite

X‐linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: Comparisons with primary myelofibrosis

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 3, 2015-03 ,pp. : E44-E48

John Wiley & Sons Inc

Access to resources Recommend Favorite